Comparing Momelotinib and Ruxolitinib in People With Untreated Myelofibrosis and Low Blood Cell Counts

NCT07498205 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

268

Enrollment

NETWORK

Sponsor class

Conditions

Myelofibrosis
Myelofibrosis (MF)

Interventions

DRUG: Momelotinib
DRUG: Ruxolitinib

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]